Profile data is unavailable for this security.
About the company
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
- Revenue in USD (TTM)1.18bn
- Net income in USD148.92m
- Incorporated1949
- Employees5.64k
- LocationStevanato Group SpAPiombino Dese (Pd) Via Molinella, 17PIOMBINO DESE 35017ItalyITA
- Websitehttps://www.stevanatogroup.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neogen Corp | 929.24m | 1.57m | 3.81bn | 2.64k | 2,436.89 | 1.21 | 32.29 | 4.10 | 0.0072 | 0.0072 | 4.29 | 14.52 | 0.2044 | 2.79 | 5.81 | 351,984.10 | 0.0345 | 3.44 | 0.0355 | 3.62 | 50.97 | 47.25 | 0.1685 | 7.77 | 2.66 | 1.37 | 0.2205 | 0.00 | 56.01 | 15.63 | -147.34 | -- | 25.71 | -- |
| Integer Holdings Corp | 1.63bn | 98.09m | 4.17bn | 10.50k | 43.19 | 2.73 | 20.94 | 2.55 | 2.88 | 2.88 | 47.86 | 45.52 | 0.5452 | 4.91 | 4.95 | 155,494.60 | 3.28 | 3.28 | 3.53 | 3.53 | 26.54 | 26.94 | 6.01 | 6.40 | 2.01 | 3.74 | 0.4303 | 0.00 | 16.03 | 5.62 | 38.71 | 9.33 | 21.71 | -- |
| Inspire Medical Systems Inc | 660.91m | -15.73m | 4.32bn | 1.01k | -- | 7.33 | -- | 6.54 | -0.5374 | -0.5374 | 22.46 | 19.85 | 1.05 | 3.14 | 10.01 | 653,721.10 | -2.50 | -11.27 | -2.80 | -12.60 | 84.65 | 84.47 | -2.38 | -13.57 | 7.25 | -- | 0.00 | -- | 53.19 | 65.32 | 52.87 | -- | 148.37 | -- |
| Haemonetics Corporation | 1.31bn | 117.56m | 4.60bn | 3.66k | 39.51 | 4.78 | 21.40 | 3.51 | 2.29 | 2.29 | 25.47 | 18.90 | 0.6339 | 2.10 | 6.79 | 357,958.70 | 5.69 | 5.02 | 6.57 | 6.07 | 53.69 | 51.74 | 8.98 | 8.11 | 1.50 | 18.09 | 0.457 | 0.00 | 12.01 | 6.23 | 1.87 | 16.40 | -11.04 | -- |
| TransMedics Group Inc | 296.92m | -10.20m | 4.92bn | 584.00 | -- | 30.74 | 4,488.80 | 16.55 | -0.335 | -0.335 | 8.96 | 4.85 | 0.5874 | 3.08 | 4.93 | 508,422.90 | -2.02 | -16.08 | -2.19 | -17.95 | 62.40 | 65.37 | -3.43 | -40.47 | 8.76 | -- | 0.7607 | -- | 158.53 | 79.36 | 30.92 | -- | 225.12 | -- |
| Merit Medical Systems Inc | 1.28bn | 101.95m | 5.03bn | 6.95k | 49.67 | 4.06 | 25.82 | 3.92 | 1.74 | 1.74 | 21.96 | 21.35 | 0.64 | 2.32 | 7.32 | 184,648.80 | 5.08 | 2.45 | 5.65 | 2.77 | 46.54 | 44.50 | 7.94 | 3.91 | 4.38 | 11.74 | 0.3922 | 0.00 | 9.24 | 7.33 | 26.70 | 15.86 | -11.16 | -- |
| DENTSPLY SIRONA Inc | 3.94bn | -95.00m | 5.72bn | 15.00k | -- | 1.75 | 22.60 | 1.45 | -0.4468 | -0.4468 | 18.69 | 15.69 | 0.5326 | 2.94 | 6.02 | 262,666.70 | -1.24 | -1.14 | -1.52 | -1.32 | 52.61 | 53.65 | -2.34 | -2.51 | 0.9692 | 3.27 | 0.3908 | -- | 1.10 | -0.1071 | 86.11 | -- | -4.54 | 9.86 |
| Masimo Corp | 1.98bn | 79.10m | 5.80bn | 3.80k | 74.43 | 4.24 | 33.02 | 2.93 | 1.46 | 1.46 | 36.54 | 25.71 | 0.6507 | 2.01 | 5.24 | 519,973.70 | 2.60 | 8.65 | 3.17 | 10.31 | 48.61 | 57.30 | 4.00 | 12.03 | 1.31 | 3.61 | 0.3909 | 0.00 | 0.6042 | 19.00 | -43.21 | -15.96 | 31.06 | -- |
| Glaukos Corp | 326.43m | -140.87m | 6.25bn | 907.00 | -- | 13.73 | -- | 19.16 | -2.88 | -2.88 | 6.68 | 9.04 | 0.3426 | 1.72 | 7.74 | 359,905.20 | -14.78 | -8.73 | -15.91 | -9.35 | 76.18 | 74.77 | -43.16 | -28.69 | 4.68 | -38.38 | 0.4395 | -- | 11.26 | 11.66 | -35.75 | -- | 14.44 | -- |
| Stevanato Group SpA | 1.18bn | 148.92m | 6.54bn | 5.64k | 38.59 | -- | 33.70 | 5.52 | 0.5616 | 0.5616 | 4.46 | -- | -- | -- | -- | 210,269.70 | -- | -- | -- | -- | 30.81 | -- | 12.57 | -- | -- | 32.91 | -- | -- | 10.34 | -- | 1.95 | -- | -- | -- |
| Repligen Corp | 607.45m | 14.84m | 7.39bn | 1.78k | 524.17 | 3.75 | 87.53 | 12.17 | 0.2524 | 0.2524 | 10.74 | 35.29 | 0.2255 | 1.43 | 4.87 | 340,689.80 | 0.551 | 4.38 | 0.6179 | 5.03 | 47.73 | 55.43 | 2.44 | 15.91 | 5.24 | -- | 0.2284 | 0.00 | -20.31 | 26.91 | -77.64 | 20.13 | 24.99 | -- |
| Penumbra Inc | 1.10bn | 93.39m | 7.88bn | 4.20k | 85.50 | 6.54 | 64.79 | 7.19 | 2.38 | 2.38 | 27.90 | 31.05 | 0.7366 | 1.03 | 5.49 | 260,899.80 | 6.28 | 2.32 | 6.98 | 2.61 | 65.04 | 63.90 | 8.52 | 3.17 | 3.51 | -- | 0.0207 | 0.00 | 24.95 | 18.93 | 4,643.16 | 68.60 | 9.64 | -- |
| Lantheus Holdings Inc | 1.37bn | 460.53m | 8.43bn | 834.00 | 18.56 | 8.91 | 16.17 | 6.17 | 6.55 | 6.55 | 19.42 | 13.64 | 0.8587 | 8.78 | 4.71 | 1,637,434.00 | 28.96 | 6.69 | 34.54 | 7.73 | 64.02 | 53.90 | 33.72 | 9.02 | 4.55 | -- | 0.3733 | 0.00 | 38.65 | 30.44 | 1,063.86 | 51.81 | 35.48 | -- |
| Bio Rad Laboratories Inc | 2.61bn | -322.37m | 8.91bn | 8.03k | -- | 1.00 | -- | 3.42 | -10.36 | -10.36 | 89.91 | 317.32 | 0.1983 | 1.58 | 5.52 | 324,438.10 | -2.45 | 9.08 | -2.56 | 9.60 | 53.53 | 55.55 | -12.37 | 41.97 | 4.89 | 0.4446 | 0.117 | 0.00 | -4.67 | 3.13 | 82.43 | -- | 3.83 | -- |
| Henry Schein, Inc. | 12.45bn | 388.00m | 9.12bn | 25.00k | 24.07 | 2.54 | 13.78 | 0.7325 | 2.96 | 2.96 | 95.11 | 28.02 | 1.33 | 4.74 | 8.00 | 498,040.00 | 4.20 | 6.09 | 6.80 | 10.44 | 31.38 | 30.04 | 3.16 | 4.40 | 1.02 | 8.26 | 0.3207 | 0.00 | -2.44 | 5.55 | -22.68 | -0.1456 | 21.27 | -- |
Data as of Jul 19 2024. Currency figures normalised to Stevanato Group SpA's reporting currency: US Dollar USD
53.46%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Conestoga Capital Advisors LLCas of 31 Mar 2024 | 6.78m | 13.70% |
| Neuberger Berman Investment Advisers LLCas of 31 Mar 2024 | 4.40m | 8.89% |
| Copeland Capital Management LLCas of 31 Mar 2024 | 2.40m | 4.86% |
| Lazard Asset Management LLCas of 31 Mar 2024 | 2.27m | 4.58% |
| Wellington Management Co. LLPas of 31 Mar 2024 | 2.13m | 4.31% |
| Sands Capital Management LLCas of 31 Mar 2024 | 1.86m | 3.76% |
| Jackson Square Partners LLCas of 31 Mar 2024 | 1.82m | 3.69% |
| ClearBridge Investments LLCas of 31 Mar 2024 | 1.73m | 3.50% |
| TimesSquare Capital Management LLCas of 31 Mar 2024 | 1.63m | 3.29% |
| William Blair Investment Management LLCas of 31 Mar 2024 | 1.43m | 2.90% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
